Association between Adherence to Secondary Prevention Therapies and Mortality in Acute Myocardial Infarction
碩士 === 國立成功大學 === 臨床藥學與藥物科技研究所 === 102 === Practice guidelines recommend that post-MI patients receive preventive therapies including anti-platelets, beta-blockers, ACEIs/ARBs, and statins, unless contraindicated. Despite the evidence supporting their use, the poor adherence has been documented. The...
Main Authors: | Tzu-ChiLiu, 劉姿祺 |
---|---|
Other Authors: | Yea-Huei Kao Yang |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/v79zfu |
Similar Items
-
Treatment and secondary prevention of myocardial infarction
by: E. V. Kuleshova, et al.
Published: (2013-12-01) -
Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data
by: Florian Kirsch, et al.
Published: (2020-12-01) -
Secondary prevention drug therapy of coronary heart disease and myocardial infarction
by: V. P. Lupanov
Published: (2013-12-01) -
Utilization and Impact of Pharmacotherapy for Secondary Prevention after Acute Myocardial Infarction (AMI)
by: I-FangChen, et al.
Published: (2012) -
PREVENTIVE ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION
Published: (2016-03-01)